|
June. 02, 2026 |
|
|
June. 04, 2026 |
|
|
jRCT1030260181 |
Clinical Performance Testing Using the Fully Automated Genetic Testing Device GENECUBE and Respiratory Pathogen Genetic Detection Reagents in Respiratory Specimens |
|
Clinical Performance Testing Using the Fully Automated Genetic Testing Device GENECUBE and Respiratory Pathogen Genetic Detection Reagents in Respiratory Specimens |
Suzuki Hiromichi |
||
University of Tsukuba Hospital |
||
2-1-1 Amakubo, Tsukuba, Ibaraki |
||
+81-29-853-3682 |
||
hsuzuki@md.tsukuba.ac.jp |
||
kaizu Asako |
||
University of Tsukuba Hospital |
||
2-1-1 Amakubo, Tsukuba, Ibaraki |
||
+81-29-853-3682 |
||
tsukuba-idcenter@gwe.md.tsukuba.ac.jp |
Recruiting |
June. 02, 2026 |
||
| 1000 | ||
Observational |
||
Patients presenting with suspected respiratory infection who have new consented specimens or residual/stored specimens such as postnasal, nasopharyngeal, pharyngeal swabs, or sputum. |
||
When consent is withdrawn |
||
| No limit | ||
| No limit | ||
Both |
||
Infectious diseases |
||
Infectious diseases |
||
D003141 |
||
Comparative performance evaluation of GENECUBE versus existing methods (e.g., LAMP) for M. pneumoniae detection in nasopharyngeal swabs. |
||
Detection of M. pneumoniae variants and drug susceptibility; evaluation of B. pertussis, C. pneumoniae, C. psittaci, Legionella, Rickettsia, Coxiella; pretreatment, composition, device settings; sensitivity, reproducibility, stability; cross-reactivity; magLEAD optimization; simultaneous detection of respiratory pathogens and resistance genes. |
||
| TOYOBO CO., LTD |
| Ethics CommitteeUniversity of Tsukuba Hospital | |
| 2-1-1 Amakubo, Tsukuba, Japan, Ibaraki | |
+81-29-853-3749 |
|
| tcr.nintei@un.tsukuba.ac.jp | |
| Approval | |
June. 23, 2022 |
No |
none |